| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |